Skip to main navigation

Close

Who We Are
Our Team
Dynamo Platform
Pipeline
Patients
Investors & Media
Careers

399 Binney Street, 2nd Floor

Cambridge, MA 02139

info@relaytx.com

(617) 370-8837

06

Investors & Media

Press Releases

Overview
News & Events
- Press Releases
- Events
Corporate Presentation
Stock Information
Governance
SEC Filings
ESG
Investor Resources

Keyword Search

Year

Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

May 5, 2022

Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference

May 3, 2022

Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights

April 28, 2022

Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

February 24, 2022

Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

February 17, 2022

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

February 2, 2022

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008

January 4, 2022

Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

January 3, 2022

Who We Are
About Us
Dynamo Platform
Pipeline
Patients
Investors & Media
Careers
Contact

Relay Therapeutics

399 Binney Street, 2nd Floor

Cambridge, MA 02139

info@relaytx.com

(617) 370-8837

© Relaytx 2022

Privacy Policy Terms of Use